Abstract
Background:In Japan, oral tacrolimus (TAC) was approved for the treatment of RA in 2005 and the improvement of symptoms thorough the use concomitant with disease modifying antirheumatic drugs (DMARDs), including...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have